1.miRNA-199 a-5 p inhibit the invasion of MDA-MB-231 cells via regulating ERK5 through SP1
Limin ZHAI ; Shuo YANG ; Wentong LI
Chinese Journal of Clinical and Experimental Pathology 2015;(9):981-985
Purpose To study the effect and mechanism of miR-199a-5p on the invasion of breast cancer MDA-MB-231 cells. Meth-ods miR-199a-5p mimic was transfected into MDA-MB-231 cells. Influence of miR-199a-5p on the invasion of MDA-MB-231 cell was displayed by Transwell, the expression of epithelial-mesenchymal transition ( EMT) molecular markers ( E-cadherin, vimentin) regulated by miR-199a-5p was determined using immunofluorescence and Western blot. Western blot was employed to assess the levels of ERK5, pERK5, EGF and SP1 in MDA-MB-231 cells dealt with miR-199a-5p mimic and LNA-siRNA. Chromatin immunoprecipita-tion (CHIP) was applied for displaying the reaction of SP1 with ERK5 promoter. Results miR-199a-5p could inhibit the invasion of MDA-MB-231 cells, decrease the expression of vimentin and enhance E-cadherin. Meanwhile, miR-199a-5p decreased the expression of ERK5 and pERK5, the levels of EGF and SP1 were also downregulated. On the contrary, the levels of EGF, SP1, ERK5 and pERK5 were enhanced by employing LNA-siRNA targeting miR-199a-5p. SP1 could bind with ERK5 promoter. Conclusions miR-199a-5p could reduce the expression of ERK5 and pERK5 through regulating EGF and SP1, which functioning the inhibitory effect on invasion of MDA-MB-231 breast cancer cells.
2.Adult reversible splenial lesion syndrome:a comparative analysis of clinical characteristics and prognosis
Shuo ZHANG ; Juan FENG ; Zhiyong ZHAI
Journal of Clinical Neurology 2015;28(6):426-430
Objective To describe the clinical and radiological characteristics, the etiology, clinical course and MRI findings and prognosis of reversible splenial lesion syndrome ( RESLES) are analyzed.Methods Clinical and MRI findings of adult patients who presented with RESLES were retrospectively reviewed.Corresponding to severity of disability using Modified Oxford Handicap Scale ( MOHS ) , patients were classified into favorable outcome group (MOHS≤2)and poor outcome group(MOHS≥3),clinical and neuroimaging features between two outcome groups were compared.Results Eight patients fulfilled the criteria were included, who suffered from a broad spectrum of disorders, including mild encephalitis/encephalopathy, Marchiafava-Bignami disease and antiepileptic drug withdrawal.MRI found a high signal lesion in the splenium with or without the other parts of corpus callosum and extracallosal involved.The hyperintensity disappeared or lapsed comfirmed by repeated MRI.There is an significant difference on symptoms of severe disturbance of consciousness during clinical course and MRI showed extracallosal lesions between two groups (P<0.05).Conclusions RESLES is a rare entity with wide clinicoradiological spectrum due to varied diseases and conditions.Although overall symptoms of patients with RESLES trend to relieve, the prognosis of patients with severe disturbance of consciousness and extracallosal lesions are unlikely to be favorable.
3.Unclassified antiphospholipid antibodies may improve the accuracy of the diagnosis of antiphospholipid antibody syndrome
Xiaodan ZHAI ; Shuo YANG ; Liyan CUI
Chinese Journal of Laboratory Medicine 2021;44(4):347-351
Antiphospholipid syndrome(APS) is a autoimmune system disorder caused by thrombosis and is usually accompanied with persistent positive. Antiphospholipid antibodies profiles(aPLs) is the key to diagnosing APS. The most frequently detectable aPLs in current clinical applications are anticardiolipin antibodies (aCL), anti-β2 glycoprotein Ⅰantibodies (anti-β2 GPI), and lupus anticoagulant (LA).However, it is found that the current laboratory diagnostic standard for APS based on these three aPL have many defects. The standard can′t meet the clinical needs. In this article, the research and development of antiphospholipid antibody in recent years are summarized, and the clinical value of non-classified standard antibodies such as IgA antibody isotype and anti-domain 1 β2-glycoprotein I antibody are reviewed.
4.Expression and correlation of PKCζ, MMP-2 and MMP-9 in breast cancer
Shuo YANG ; Hongli LI ; Wentong LI ; Lu YANG ; Ming NI ; Limin ZHAI ; Chonggao YIN ; Baogang ZHANG
Chinese Journal of Clinical and Experimental Pathology 2014;(9):958-962
Purpose To investigate the expressions of PKCζ, MMP-2, and MMP-9 in breast cancer and the relationship with the inva-sion and metastasis of breast cancer. Methods The expression of PKCζ, MMP-2 and MMP-9 in 100 cases with breast cancer was as-sessed with immunohistochemistry PV 9000 method. PKCζ-siRNA was transfected into MDA-MB-231 cell lines, called siPKCζ/MDA-MB-231. While siRNA construct containing a scrambled sequence was transfected into MDA-MB-231 cells to generate control cells, which were designated as Scr/MDA231 cells. Western blotting was used to measure the expression of PKCζ in transfected cells, and the Transwell invasion assay was used to detect the invasion ability in vitro. The content of MMP-2, MMP-9 were measured by ELISA. Results The expression rates of PKCζ, MMP-2 and MMP-9 in breast cancer tissues were 62.5%, 37.5% and 32.5%, and there were significant differences among them (P<0.05). The expression of PKCζwas much higher than those in the normal breast tissues nearby. The expression of PKC protein was assoiated with lymph node metastasis, distant metastasis (P<0.01), but was not correla-ted with other clinicopathologic parameters, such as age, tumor size, histological type, ER, PR, and so on (P>0.05). The expres-sion of PKCζ, MMP-2 and MMP-9 were lower in siPKCζ/ MDA-MB-231 group than those in scr/ MDA-MB-231 group, and the in vitro invasion ability was significantly decreased (P<0.05). Conclusions PKCζ can promote the invasion and metastasis of breast canc-er, and correlated with the expression of MMP-2, MMP-9(P<0.05).
5.Meta Analysis of Efficacy and Safety of Ropinirole in the Treatment of Parkinson’s Disease
Mingyue ZHAI ; Shuo ZHANG ; Ligang JIANG
Journal of Apoplexy and Nervous Diseases 2020;37(3):232-236
Objective To investigate the efficacy and safety of ropinirole in treating Parkinson’s Disease (PD) by meta-analysis of clinical randomized controlled studies. Methods The American national Library of medicine (Pubmed),Cochrane Library (Cochrane Library),Dutch medical literature database (Embase),CNKI (CNKI),wanfang knowledge service platform,and wiper journal network were searched by computer to search the relevant studies on the efficacy and safety of ropinello in the treatment of Parkinson’s disease. The scores of the unified Parkinson’s disease assessment scale part Ⅱ (UPDRS Ⅱ),part Ⅲ (UPDRS Ⅲ) and the incidence of adverse events in each group were extracted. Cochrane risk bias assessment tool was used to evaluate the quality of the included literature,and RevMan5.3 software was used for Meta analysis. Results A total of 732 articles were found through computer database retrieval,and 12 RCT studies on the efficacy and safety of PD treatment with ropinero were finally included,including 1855 patients in the experimental group and 1486 patients in the control group. Results of meta-analysis showed that,compared with placebo group,the scores of UPDRS Ⅱ(MD -2.23,95%CI -2.82~-1.64,P<0.00001) and UPDRS Ⅲ(MD -4.93,95%CI -5.25~-4.61,P<0.00001) in the treatment of Parkinson’s disease in the ropinelo group were more significantly reduced in terms of drug efficacy. In terms of the incidence of adverse reactions,the incidence of dyspraxia (RR 3.67,95%CI 2.57~5.24,P<0.00001),dizziness (RR 1.85,95%CI 1.50~2.28,P<0.00001),nausea (RR 2.17,95%CI 1.81~2.59,P<0.00001),vomiting (RR 2.73,95%CI 1.47~5.09,P=0.001) and sleepiness (RR 2.19,95%CI 1.39~3.44,Both P=0.0007) were higher than those in the placebo group,with statistically significant differences. The incidence rates of headache (RR 1.14,95%CI 0.79~1.65,P=0.49),insomnia (RR 1.06,95%CI 0.72~1.55,P=0.17),postural hypotension (RR 1.35,95%CI 0.81~2.22,P=0.25) and constipation (RR 1.03,95%CI 0.71~1.50,P=0.87) were all lower than those of the placebo group,with no statistically significant difference. Conclusion In this study,the method of meta-analysis showed that the improvement rate of daily living ability and motor function score of PD patients treated with ropinelol was significantly higher than that of patients receiving placebo. Ropinelol was well tolerated and safe,and most adverse reactions were related to peripheral dopaminergic activities.
6.The diagnostic value of miR-571 levels in blood from the peripherals in liver fibrosis
Juan TANG ; Yi LI ; Liqiong ZHAI ; Shaowen LIU ; Yong SHEN ; Shuo CONG ; Yongmei LIU
The Journal of Practical Medicine 2024;40(5):653-657
Objective To study the diagnostic value of miR-571 for liver fibrosis by detecting miR-571 expression in the peripheral blood of patients with liver fibrosis.Methods From December 2022 to September 2023,40 patients with liver fibrosis,40 patients with chronic hepatitis,and 40 healthy controls were chosen as research subjects.The expression level of miR-571 in peripheral blood was detected using a real-time quantitative polymerase chain reaction,and the relative expression of miR-571 in each group was evaluated.The Spearman correlation method was utilized to examine the relationship between miR-571 and clinical detection indices.To assess the capacity of miR-571 and the multivariate diagnostic model to identify liver fibrosis,binary logistic regression was used to create a multivariate diagnostic model,and ROC curves were generated.Results The expression of miR-571 was significantly higher in the liver fibrosis group than in the healthy control and hepatitis groups,and the difference was statistically significant(P<0.001).The expression level of miR-571 was positively connected with ALT,APRI score,and FIB-4 index(r = 0.23,0.30,0.22,P<0.05)and negatively correlated with PLT(r =-0.19,P<0.05)according to Spearman correlation analysis.Logistic regression research revealed that miR-571 and the FIB-4 index were independent risk factors for liver fibrosis.The AUC for miR-571 to diagnose fibrosis was 0.91(95%CI:0.85~0.96),while the AUC for miR-571 paired with the FIB-4 index was 0.94(95%CI:0.90~0.98).Conclusion MiR-571 expression was shown to be considerably higher in the peripheral blood of hepatic fibrosis patients,and the combined FIB-4 index offers some clinical diagnostic value for hepatic fibrosis.
7.Applicability assessment and application of the general self-efficacy scale among medical postgraduates
Chi ZHANG ; Ping ZENG ; Deping LIU ; Yuanyuan WANG ; Helong ZHANG ; Yan WANG ; Shuo ZHAI ; Xiaoying SHAO
Chinese Journal of Medical Education Research 2022;21(2):135-140
Objective:To assess the reliability, constructive validity and item characteristics of the general self-efficacy scale (GSES) among Chinese medical postgraduates using classical test theory and item response theory.Methods:A questionnaire survey was conducted among 1 021 medical postgraduates from 6 comprehensive level Ⅲ A hospitals in Beijing. Demographic characteristics and general self-efficacy were investigated. SPSS 24.0 software was used for statistical analysis. Internal consistency of the GSES was evaluated using Cronbach’s α coefficient and intraclass correlation coefficient. Factor analyses were implemented to test the structure of the scale. An item response theory (IRT) framework with a graded response model was performed to estimate the parameters of each item. Results:The overall Cronbach’s α coefficient of the GSES was 0.92. Parallel analysis and confirmatory factor analysis supported the unidimensional structure of the GSES. The discrimination parameter of the 10 items ranged from 1.82 to 3.65, and the difficulty parameter ranged from -3.51 to 1.66, with a monotonically increasing trend. The maximum test information of the scale among medical postgraduates was 19.16. Conclusion:The GSES has good reliability, validity and measurement precision, showing a good applicability in the survey of medical postgraduates. However, the difficulty of specific items is relatively low, and the scale may be further optimized and improved.
8.Quality Evaluation of Branches of Juglans mandshurica by HPLC-DAD Fingerprint Combined with HPLC-Q-TOF-MS/MS Characterization of Constituents
Hong LIU ; Xiao-chang JU ; Feng-shuo SHI ; Xue DI ; Hong-he XIAO ; Hui ZHANG ; Yan-jun ZHAI ; Tian-min WANG
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(9):137-146
Objective:To establish a high performance liquid chromatography (HPLC) fingerprint of branches of
9.Visceral leishmaniasis in Xinjiang Uygur Autonomous Region during the COVID-19 pandemic: a case report
Wumaier MAIMAITIJIANG ; Xiaohu ZHAI ; Keyoumu AYIXIAMU ; Guangzhong SHI ; Shuo WANG ; Xia CHENG ; Eemayil KADERYA ; Jiangshan ZHAO
Chinese Journal of Schistosomiasis Control 2023;35(2):213-216
Objective To perform an epidemiological investigation on a case of visceral leishmaniasis reported from Shule County, Kashi Prefecture, Xinjiang Uygur Autonomous Region in 2021, so as to provide insights into differential diagnosis of visceral leishmaniasis during the COVID-19 pandemic. Methods The epidemiological history of this case was collected, and the case was diagnosed for Leishmania infection with the immunochromatographic (rK39) strip test, bone marrow smear microscopy and PCR assay. Results The patient had typical clinical symptoms of leishmaniasis, including irregular fever, hepatosplenomeg- aly, low serum albumin and elevated globulin. Bone marrow smear microscopy identified L. donovani amastigotes, and both rK39 strip test and PCR assay were positive, while the case was tested negative for SARS-CoV-2. COVID-19 was therefore excluded and visceral leishmaniasis was diagnosed. Standard full-dose treatment with sodium stibogluconate was given, and no Leishmania was found on blood smears during the reexamination. No recurrence was found during the followup after discharge for hospital. Conclusions During the COVID-19 pandemic, it is recommended to increase the perception of differential diagnosis of visceral leishmaniasis among first-contact doctors, and reinforce the capability of differential diagnosis and health education of visceral leishmaniasis among medical and healthcare institutions at all levels, to prevent missed diagnosis and misdiagnosis of visceral leishmaniasis.
10.Curcumin inhibits the replication of enterovirus 71 in vitro.
Ying QIN ; Lexun LIN ; Yang CHEN ; Shuo WU ; Xiaoning SI ; Heng WU ; Xia ZHAI ; Yan WANG ; Lei TONG ; Bo PAN ; Xiaoyan ZHONG ; Tianying WANG ; Wenran ZHAO ; Zhaohua ZHONG
Acta Pharmaceutica Sinica B 2014;4(4):284-294
Human enterovirus 71 (EV71) is the main causative pathogen of hand, foot, and mouth disease (HFMD) in children. The epidemic of HFMD has been a public health problem in Asia-Pacific region for decades, and no vaccine and effective antiviral medicine are available. Curcumin has been used as a traditional medicine for centuries to treat a diversity of disorders including viral infections. In this study, we demonstrated that curcumin showed potent antiviral effect again EV71. In Vero cells infected with EV71, the addition of curcumin significantly suppressed the synthesis of viral RNA, the expression of viral protein, and the overall production of viral progeny. Similar with the previous reports, curcumin reduced the production of ROS induced by viral infection. However, the antioxidant property of curcumin did not contribute to its antiviral activity, since N-acetyl-l-cysteine, the potent antioxidant failed to suppress viral replication. This study also showed that extracellular signal-regulated kinase (ERK) was activated by either viral infection or curcumin treatment, but the activated ERK did not interfere with the antiviral effect of curcumin, indicating ERK is not involved in the antiviral mechanism of curcumin. Unlike the previous reports that curcumin inhibited protein degradation through ubiquitin-proteasome system (UPS), we found that curcumin had no impact on UPS in control cells. However, curcumin did reduce the activity of proteasomes which was increased by viral infection. In addition, the accumulation of the short-lived proteins, p53 and p21, was increased by the treatment of curcumin in EV71-infected cells. We further probed the antiviral mechanism of curcumin by examining the expression of GBF1 and PI4KB, both of which are required for the formation of viral replication complex. We found that curcumin significantly reduced the level of both proteins. Moreover, the decreased expression of either GBF1 or PI4KB by the application of siRNAs was sufficient to suppress viral replication. We also demonstrated that curcumin showed anti-apoptotic activity at the early stage of viral infection. The results of this study provide solid evidence that curcumin has potent anti-EV71 activity. Whether or not the down-regulated GBF1 and PI4KB by curcumin contribute to its antiviral effect needs further studies.